Related Experiment Video
Updated: Mar 22, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
8.0K
Parkinson's Disease: A Traffic Jam?
Michael J Clague1, Leila Rochin1
1Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK.
Current Biology : CB
|April 27, 2016
Summary
Parkinson's disease kinases LRRK2 and PINK1 converge to phosphorylate Rab GTPases, impacting membrane trafficking pathways. This finding reveals a shared mechanism in Parkinson's disease pathogenesis.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Parkinson's disease is a neurodegenerative disorder linked to specific protein kinases.
- LRRK2 and PINK1 are key kinases implicated in Parkinson's disease pathogenesis.
- The precise molecular mechanisms by which these kinases contribute to the disease are under investigation.
Purpose of the Study:
- To investigate the convergence of LRRK2 and PINK1 signaling pathways.
- To identify common downstream targets of LRRK2 and PINK1 activation.
- To understand the role of these kinases in regulating cellular processes relevant to Parkinson's disease.
Main Methods:
- Large-scale proteomic analysis was employed.
- Phosphoproteomic profiling was performed on cells with activated LRRK2 and PINK1.
- Comparative analysis of phosphoproteomic data was conducted.
Main Results:
- Activation of both LRRK2 and PINK1 leads to the phosphorylation of Rab family small GTPases.
- A significant convergence was observed in the phosphoproteome alterations caused by these two kinases.
- Rab GTPase phosphorylation suggests a shared impact on membrane trafficking.
Conclusions:
- LRRK2 and PINK1 share a common downstream pathway involving Rab GTPase phosphorylation.
- This convergence highlights a potential unified mechanism in Parkinson's disease pathology.
- Targeting this shared pathway may offer therapeutic strategies for Parkinson's disease.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:37Neural Regulation
44.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.5K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.4K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.4K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
01:29Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K